Age-related normative changes in cerebral perfusion: data from The Irish Longitudinal Study on Ageing (TILDA) by Ní Leidhin, Caoilfhionn et al.
NeuroImage 229 (2021) 117741 
Contents lists available at ScienceDirect 
NeuroImage 
journal homepage: www.elsevier.com/locate/neuroimage 
Age-related normative changes in cerebral perfusion: Data from The Irish 
Longitudinal Study on Ageing (TILDA) 
Caoilfhionn Ní Leidhin a , b , Jason McMorrow a , b , Daniel Carey a , c , Louise Newman a , c , 
Wilby Williamson a , d , Andrew J. Fagan e , Michael A. Chappell f , g , h , i , Rose Anne Kenny a , c , d , j , 
James F. Meaney a , b , Silvin P. Knight a , c , ∗ 
a School of Medicine, Trinity College Dublin, Ireland 
b The National Centre for Advanced Medical Imaging (CAMI), St. James’s Hospital, Dublin, Ireland 
c The Irish Longitudinal Study on Ageing (TILDA), Trinity College Dublin, Ireland 
d The Global Brain Health Institute (GBHI), Trinity College Dublin, Ireland 
e Department of Radiology, Mayo Clinic, Rochester, MN, USA 
f Radiological Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, United Kingdom 
g Sir Peter Mansfield Imaging Center, School of Medicine, University of Nottingham, Nottingham, United Kingdom 
h Nottingham Biomedical Research Centre, Queens Medical Centre, University of Nottingham, Nottingham, United Kingdom 
i Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom 
j Mercer’s Institute for Successful Ageing, St. James’s Hospital, Dublin, Ireland 
a r t i c l e i n f o 
Keywords: 
Cerebral blood flow 
Cerebral perfusion 





a b s t r a c t 
Objective: To establish normative reference values for total grey matter cerebral blood flow (CBF GM ) measured 
using pseudo-continuous arterial spin labelling (pCASL) MRI in a large cohort of community-dwelling adults aged 
54 years and older. 
Background: Quantitative assessment of CBF GM may provide an imaging biomarker for the early detection of 
those at risk of neurodegenerative diseases, such as Alzheimer’s and dementia. However, the use of this method 
to differentiate normal age-related decline in CBF GM from pathological reduction has been hampered by the lack 
of reference values for cerebral perfusion. 
Methods: The study cohort comprised a subset of wave 3 (2014–2015) participants from The Irish Longitudi- 
nal Study on Ageing (TILDA), a large-scale prospective cohort study of individuals aged 50 and over. Of 4309 
participants attending for health centre assessment, 578 individuals returned for 3T multi-parametric MRI brain 
examinations. In total, CBF GM data acquired from 468 subjects using pCASL-MRI were included in this analysis. 
Normative values were estimated using Generalised Additive Models for Location Shape and Scale (GAMLSS) and 
are presented as percentiles, means and standard deviations. 
Results: The mean age of the cohort was 68.2 ± 6.9 years and 51.7% were female. Mean CBF GM for the cohort was 
36.5 ± 8.2 ml/100 g/min. CBF GM decreased by 0.2 ml/100 g/min for each year increase in age (95% CI = − 0.3, 
− 0.1; p ≤ 0.001) and was 3.1 ml/100 g/min higher in females (95% CI = 1.6, 4.5; p ≤ 0.001). 
Conclusions: This study is by far the largest single-site study focused on an elderly community-dwelling cohort to 
present normative reference values for CBF GM measured at 3T using pCASL-MRI. Significant age- and sex-related 

















The world population aged 60 years and older is predicted to in-
rease from 900 million to 2.1 billion between 2015 and 2050, with
n anticipated 350% increase in individuals aged 80 years or older
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mpose profound socioeconomic stresses on healthcare systems. 
Vascular disease is an important contributor to brain ageing and de-
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a  or substrate storage, strict control of cerebral blood flow (CBF) via
etabolic, autonomic and cerebral autoregulation is critical to en-
ure adequate oxygen and nutrient supply to the brain ( Willie et al.,
014 ). Cerebral hypoperfusion has been suggested as a potential link
etween vascular damage and dementia, with prior studies having re-
orted lower cerebral perfusion in patients with mild cognitive im-
airment and dementia ( Leijenaar et al., 2017 ; Luckhaus et al., 2008 ;
olters et al., 2017 ). Additionally, a reduction in CBF in high-risk
ubjects for Alzheimer’s disease has been reported to occur before the
nset of cognitive decline, brain atrophy or amyloid- 𝛽 accumulation
 Zhang et al., 2017 ), suggesting that cerebral hypoperfusion may act
s a biomarker heralding Alzheimer’s disease. Once detected, it could
otentially offer a target for intervention. However, since ageing itself
s associated with impaired regulatory mechanisms and therefore lower
BF, a significant challenge for researchers and clinicians is to distin-
uish normal age-related decline in cerebral perfusion from pathological
eduction. 
Accurate measurement of cerebral perfusion has proved challeng-
ng, with most techniques being costly, invasive, relying on exposure to
onising radiation and/or subject to operator variability. Arterial spin
abelling (ASL) is an MRI technique that uses inflowing magnetically-
abelled arterial blood as an endogenous tracer to measure cerebral
aemodynamics and provides a quantitative, non-invasive, non-ionising
easure of CBF. This method is gaining acceptance as an optimal tech-
ique for population-based CBF assessment ( Wintermark et al., 2005 ),
ith high concordance rates reported between ASL-MRI and [ 15 O]-
ater positron emission tomography (PET); currently considered the
gold standard’ for measuring whole brain perfusion ( Fan et al., 2016 ). 
Given the lack of reference values for cerebral perfusion measured
sing ASL-MRI, this study was performed to establish normative values
or CBF in a large cohort of community-dwelling adults aged 54 years
nd older. 
. Materials and methods 
.1. Subject cohort – The Irish Longitudinal Study on Ageing (TILDA) 
This research was carried out on a subset of participants enrolled
n The Irish Longitudinal Study on Ageing (TILDA), which is described
n detail in previous publications ( Kearney et al., 2011 ; Whelan and
avva, 2013 ). In brief, TILDA is a prospective, cohort study, which col-
ects health, economic and social data from nationally-representative,
ommunity-dwelling Irish adults and investigates how various factors
nteract. 8507 adults were enrolled in the first wave of TILDA (2009–
010). 
The cohort used in the present study was comprised of a subset of
ILDA wave 3 (2014–2015) participants. Of 4309 participants attending
or health assessment in a dedicated health assessment centre, a random
ubset was invited to return for multi-parametric brain MRI at the Na-
ional Centre for Advanced Medical Imaging (CAMI), Dublin, Ireland.
articipants were excluded if they had a contraindication to MRI or a
rior stroke/head injury. MRIs were performed between May 2014 and
une 2015. A total of 560 scans were obtained from 578 subjects attend-
ng for MRI ( Donoghue et al., 2018 ). T 1 -weighted and ASL data were
vailable for 546 participants (attrition due to claustrophobia or inabil-
ty to complete scan - pCASL data was acquired last in the examination
equence). 
A trained operator (DC) who was blind to participant identity
creened all T 1 -weighted imaging for image artefacts and/or pathology.
2 subjects were excluded due to abnormalities on T 1 -weighted imag-
ng. Among those, sixteen had gross abnormality corresponding to con-
uent white matter hyperintensities on T 2 and FLAIR imaging, four had
stablished large vessel infarcts and two had MRI evidence of prior con-
usion/haemorrhage. One patient with Parkinson’s disease, four with a
istory of stroke and four with a Mini Mental State Examination (MMSE)
core < 24 were also excluded from data analysis. Another trained oper-2 tor (CNL) who was blind to participant identity reviewed all perfusion
aps for evidence of arterial artefact, poor labelling of a feeding artery,
evere motion and/or other gross failure to produce a perfusion image
see Appendix 1 for further details). By consensus between CNL and
C, 29 subjects with abnormal perfusion maps were removed from the
ohort. Of those, 18 were excluded due to labelling failure, 4 due to de-
ayed arrival and 7 due to severe motion (see Appendix 1 for examples).
n additional three subjects were removed as outliers due to extreme
hole brain CBF GM values ( < 10 (n = 1) or > 100ml/100g/min. (n = 2)).
dditionally, 15 were excluded due to extremes of age. The small num-
ers of participants aged younger than 54 and older than 84 would result
n unreliable normative value estimates. This left a total of 468 subjects
or whom CBF data were available. Exclusionary criteria leading to the
nal sample are illustrated in the Fig. 1 . 
.2. TILDA health assessment 
The comprehensive TILDA health assessment has been described
n detail elsewhere ( Cronin et al., 2013 ; Kenny et al., 2013 ). Socio-
emographic, behavioural and physical health characteristics of par-
icipants were recorded. These included age, sex, self-reported alco-
ol consumption, smoking status and cardiovascular conditions. Use of
ntihypertensive medication(s) was documented. Physical measures in-
luding height and weight (thereby allowing calculation of body mass
ndex [BMI]), blood pressure (static seated and standing, as well as
ynamic beat-to-beat variability) and pulse wave velocity were also
ecorded. Participants were screened for depression and cognitive im-
airment/dementia using the Center for Epidemiologic Studies Depres-
ion scale (CESD) and Mini-Mental State Examination (MMSE) respec-
ively. 
.3. MRI data acquisition 
All MRI examinations were performed on a 3T system ( Achieva ,
hilips Medical Systems, The Netherlands), using a 32-channel head
oil. The MRI protocol included T 1 -weighted and ASL sequences. T 1 -
eighted 3D magnetization-prepared rapid gradient echo (MPRAGE)
natomical images were acquired over 5 min 24 s with the following
can parameters: field of view (FOV) = 240 × 240 × 162 mm 3 , ma-
rix = 288 × 288 × 180, repetition time (TR) = 6.7 ms, echo time
TE) = 3.1 ms, flip angle = 8°, and SENSE = 2. The specific ASL imple-
entation used in this study was pseudo-continuous ASL (pCASL). This
nvolves the application of a closely spaced train of inversion pulses to
abel upstreaming arterial blood in the neck, followed by a delay to al-
ow the labelled blood to perfuse the brain tissue and finally, imaging
f the perfused brain. Imaging was achieved via 2D multislice single
hot echo-planar imaging (EPI). The distance between the centre of the
maged volume and the centre of the labelling slice was 90 mm. Posi-
ioning the labelling plane 32 mm below the base of the imaging vol-
me ensured that the feeding (carotid) arteries were consistently per-
endicular to the labelling plane and below the inferior border of the
erebellum. This prescription further ensured the labelling plane was
emote from regions of strong susceptibility artefacts such as air/tissue
nterfaces. Background tissue suppression was performed twice during
he pCASL sequence. First, prior to the labelling block, pre-saturation
f the tissue within the imaged volume was performed using WET (wa-
er suppression enhanced through T 1 effects) ( Ogg et al., 1994 ). Second,
wo 180° inversion pulses were applied between the labelling and image
cquisition blocks. The first inversion pulse was selective to the imaged
olume and was applied 60 ms after the end of the labelling pulse, while
he second was non-selective and was applied 1,080 ms after the end
f the labelling pulse. Two inversion pulses were found to represent a
ood trade-off between background tissue suppression and ASL signal.
CASL acquisition parameters were as follows: FOV = 240 × 240 mm 2 ,
atrix = 80 × 80, TR = 4000 ms, TE = 9 ms, FA = 90°, SENSE = 2.5,
nd scan duration = 4 min 16 s. 13 slices (8 mm thick, 1 mm gap) were
C.N. Leidhin, J. McMorrow, D. Carey et al. NeuroImage 229 (2021) 117741 










































w  cquired sequentially in a caudocranial direction, yielding 30 dynamic
cans and 780 images in total (390 labelled, 390 unlabelled). An imag-
ng volume of 116 mm was considered a compromise between covering
s much of the brain as possible and limiting MRI acquisition time, in
his older cohort. A labelling duration of 1800 ms and a post-label de-
ay (PLD) of 1800 ms were used, as recommended in the ASL consensus
aper ( Alsop et al., 2015 ). Given the broad age range among the study
ohort (53–84, mean 68.5 years) and the desire to use a consistent acqui-
ition protocol, a PLD of 1800 ms was employed. This took into account
he 2D multi-slice readout and consequent prolonged PLDs in more su-
erior slices. This PLD would ideally minimize large vessel arterial in-
ow signal in the pCASL images, while maximizing signal-to-noise ratio
 Haller et al., 2016 ) in this older cohort with presumed longer arterial
rrival times. 
Calibration scans measuring the equilibrium magnetisation ( M 0 )
ere also acquired using the same geometry as the pCASL sequence,
ith TR = 10,000 ms, TE = 9 ms, and scan duration = 20 s. B 0 field
aps were measured using a two-echo 2D gradient echo sequence with
he same in-plane resolution as the pCASL scans and the following ac-
uisition parameters: 38 slices (3.2 mm slice thickness, 0.3 mm slice
ap), TR = 455 ms, TE 1 / TE 2 = 1.69 / 7.0 ms, FA = 90°, and scan
uration = 39 s. 
3 .4. MRI analysis 
MRI analysis was performed using Oxford_ASL v4.0 in FMRIB Soft-
are Library (BASIL - FSL; Oxford Centre for Functional MRI of the Brain,
xford, UK, HYPERLINK " https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/BASIL )
 Chappell et al., 2009 ; Groves et al., 2009 ; Woolrich et al., 2009 ). Quan-
ification in BASIL used the standard well-mixed single compartment
inetic model with no dispersion of the bolus of labelled blood water
 Buxton, 2005 ). A tissue T 1 value of 1300 ms and an arterial blood T 1 of
,650 ms were assumed, along with a blood-brain partition coefficient of
.9. The labelling efficiency was set at 0.85 ( Alsop et al., 2015 ). Slice-
iming effects, which increase the PLD for more superior slices, were
orrected for a slice delay of 30 ms. Motion correction was performed
n the raw ASL data within BASIL using FSL MCFLIRT. Adaptive spatial
egularisation was used to decrease the appearance of noise in the final
erfusion image ( Groves et al., 2009 ). Perfusion images were reviewed
or evidence of image artefacts, as described previously. Anatomical pro-
essing was performed using the fsl_anat function, including segmenta-
ion and registration to MNI152 standard space. BASIL performed linear
egistration of the perfusion image to the anatomical image. B 0 maps
ere used to apply distortion corrections to the pCASL images in order


























































Characteristics of study sample. 
Study Cohort ( N = 468) 
Age [years] 
Male 68.4 (SD: 7.2, range: [53–84]) 
Female 68.0 (SD: 6.7, range: [53–84]) 
Sex [% (n)] Female: 51.7% (242) 
Education [% (n)] 
Primary/None 19.7% (92) 
Secondary 36.3% (170) 
Third/Higher 44.0% (206) 
Mean BMI [kg/m 2 ] 27.8 (SD: 4.3, range: [17.9–45.8]) 
Self-reported diabetic [% (n)] 
Yes 7.9% (37) 
Number of Cardiovascular Conditions a [% (n)] 
0 38.5% (180) 
1 35.9% (168) 
2 + 25.6% (120) 
High Blood Pressure [% (n)] 
Yes 34.2% (160) 
High Cholesterol [% (n)] 
Yes 36.1% (169) 
Mean Systolic BP [mmHg] 134.4 (SD: 19.3, range: [87.0–212]) 
Mean Diastolic BP [mmHg] 80.1 (SD: 10.5, range: [51.5–118]) 
Mean MAP [mmHg] 98.2 (SD: 12.5, range: [64.5–144]) 
Mean PWV [m/s] 10.8 (SD: 2.0, range: [5.8–18.6]) 
Antihypertensive Medication Use b [% (n)] 
Yes 39.5% (185) 
CAGE Alcohol Scale [% (n)] 
CAGE < 2 80.1% (375) 
CAGE ≥ 2 9.0% (42) 
No response 10.9% (51) 
Smoker [% (n)] 
Never 50.9% (238) 
Past 42.5% (199) 
Current 6.6% (31) 
CESD [% (n)] 
Non-depressed (CESD < 9) 90.6% (424) 
Depressed (CESD ≥ 9) 9.4% (44) 
Mean MMSE 28.9 (SD: 1.3, range: [24–30]) 
Mean CBF GM [ml/100g/min] 36.5 (SD: 8.2, range: [12.9–66.4]) 
a Cardiovascular conditions: high cholesterol; high blood pressure; angina; 
heart attack ever; heart failure, murmur, abnormal rhythm; stroke ever, TIA 
ever. 
b Coded using the Anatomical Therapeutic Chemical Classification (ATC): an- 
tihypertensive medications (ATC C02), diuretics (ATC C03), 𝛽-blockers (ATC 
C07), calcium channel blockers (ATC C08), and renin-angiotensin system agents 
(ATC C09) Abbreviations: BMI, body mass index; PWV, pulse wave velocity; BP, 
blood pressure; MAP, mean arterial pressure; CESD, Center for Epidemiologic 
Studies Depression scale; MMSE, Mini-Mental State Examination; CBF GM , grey 

















t  o compensate for any spatially nonlinear image distortion effects that
 0 inhomogeneities may have had on these EPI data. 
Voxel-wise absolute perfusion values (CBF in ml/100g/min) were
alculated using the calibration ( M 0 ) data ( Alsop et al., 2015 ). M 0 val-
es for arterial blood were estimated indirectly using cerebrospinal fluid
CSF) as a ‘reference-tissue’ (measured in the ventricles using an auto-
atically generated mask in BASIL that is based on a combination of
he CSF segmentation from fsl_anat and the ventricular regions of inter-
st in the Harvard-Oxford Atlas). A correction was made for incomplete
ecovery of the signal based on the TR and an assumed T 1 value for
SF (4300 ms), as well as the differences in T 2 values between tissue
150 ms) and CSF (750 ms). Mean whole brain grey matter cerebral
lood flow (CBF GM ) was calculated in the native space of the perfusion
mage. In order to create a grey matter mask, the grey matter partial vol-
me estimates from the structural segmentation were transformed into
CASL space and a threshold of 70% grey matter applied ( Chappell et al.,
017 ). A reasonably conservative threshold of 70% grey matter was cho-
en to reduce the partial volume effect on mean GM values. 
.5. Statistical analysis 
Generalised Additive Models for Location, Shape and Scale
GAMLSS), calculated in statistical software R (version 3.4.3, MA, USA)
ere used to estimate normative reference values for CBF GM . CBF GM was
odelled using the Box-Cox Power Exponential distribution, which has
our parameters corresponding to location, scale, skew and kurtosis of
he distribution ( Rigby and Stasinopoulos, 2005 ; Rigby and Stasinopou-
os, 2004 ). Age was included as a continuous variable in the models,
ith sex as a covariate. Interactions between age and sex were also con-
idered. Restricted cubic splines were used in the models to account for
he potentially non-linear relationship between CBF and age. Model se-
ection utilised a forward and backward stepwise selection criteria based
n the Akaike Information Criterion. CBF GM is reported for the 5th, 10th,
5th, 50th, 75th, 90th and 95th percentiles for each sex for every fifth
ear of age from 54 and 84. Statistical analysis also included linear re-
ressions performed in STATA (12.1, StataCorp, TX, USA). Statistical
ignificance was set at p < 0.05. 
. Results 
.1. Subject characteristics 
Mean (SD) age at the time of scanning was 68.4 (7.2) years for males
nd 68.0 (6.7) years for females. 51.7% of participants were female
able 1 . 
.2. Cerebral perfusion values 
Mean CBF GM was 36.5 ± 8.2 ml/100 g/min; range: [12.9–
6.4 ml/100 g/min]. CBF GM decreased by 0.2 ml/100 g/min with every
ne year increase in age (95% CI = − 0.3, − 0.1, p ≤ 0.001; model adjusted
or sex) and was 3.1 ml/100 g/min higher in females (95% CI = 1.6, 4.5,
 ≤ 0.001; model adjusted for age) Figure 2 . 
Normative reference values for CBF GM are presented in Table 3 and
llustrated in Fig. 3 , stratified by age and sex according to percentiles.
n men, average CBF GM decreased by 15.2% across the age range
ested from 37.6 ml/100 g/min (interquartile range [IQR]: 32.1–
2.1 ml/100 g/min) in the youngest (54 years) to 31.9 ml/100g/min
IQR: 27.3–35.8 ml/100 g/min) in the oldest (84 years). A simi-
ar trend was observed in women, with average CBF GM decreasing
3.7 % from 41.0 ml/100 g/min (IQR: 35.1–46.0 ml/100 g/min) to
5.4 ml/100 g/min (IQR: 30.3–39.7 ml/100 g/min) across the same
ge range. Reference curves ( Fig. 3 ) demonstrate linear CBF GM decline
ith age. 4 .3. Cardiovascular determinants of cerebral perfusion 
CBF GM decreased by 0.06, 0.14, and 0.11 ml/100 g/min per 1 mmHg
ncrease in systolic blood pressure (BP) ( p ≤ 0.001, 95% CI = − 0.10,
 0.03), diastolic BP ( p ≤ 0.001, 95% CI = − 0.20, − 0.07) mean ar-
erial pressure (MAP) ( p ≤ 0.001, 95% CI = − 0.17, − 0.06) respec-
ively, all models adjusted for age and sex. CBF GM decreased by
.35 ml/100 g/min for each 1 unit increase in body mass index
 p ≤ 0.001, 95% CI = − 0.51, − 0.18; model adjusted for age and sex).
here was no significant association between grey matter perfusion and
elf-reported educational attainment, diabetes, number of cardiovascu-
ar conditions, high blood pressure, hypercholesterolaemia, antihyper-
ensive medication(s), CAGE score > 2, smoking, depression, or MMSE
erformance. For further details see Table 2 . 
. Discussion 
With increasing age, there is both a decline in CBF GM and in the reg-
latory mechanisms that maintain adequate brain perfusion. To date,
he lack of published CBF GM normative values in large populations has
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Fig. 2. Example of processed perfusion map measured with ASL from a 65-year-old female participant. 
Fig. 3. Age-dependence of total grey matter 
cerebral blood flow (CBF GM ) stratified by sex, 
for men (top) and women (bottom). Figure dis- 
plays normative values for grey matter CBF ac- 








































p  indered acceptance of this potentially useful biomarker in distinguish-
ng normal age-related decline in CBF GM from pathological reduction.
n this study, normative CBF GM values measured using pCASL-MRI in
68 community-dwelling subjects are presented. 
Consistent with prior studies using various imaging modali-
ies( Chen et al., 2011 ; De Vis et al., 2015 ; Liu et al., 2012 ; Lu et al., 2011 ;
arkes et al., 2004 ; Selim et al., 2008 ; Soni et al., 2016 ; Vernooij et al.,
008 ; Wolters et al., 2017 ), this research demonstrates declining cere-
ral blood flow with advancing age. Reference curves demonstrate lin-
ar decline in CBF GM with age, with comparable overall CBF GM decrease
ith time in men and women. 
Few studies to date have reported on CBF values in older adults
nd of those that have, a consensus on normative CBF values has not
een reached. Direct comparison between the present study and pre-
ious ones is limited due to significant variations in study methodolo-
ies. However, the present study followed best-practice ISMRM consen-
us guidelines and results are in line with those where CBF was mea-
ured using 3T pCASL-MRI according to ISMRM recommendations. Fol-
owing a similar protocol to ours, Jefferson et al. reported mean total
hole brain CBF values of 37.3 ± 7.1 ml/100 g/min for 270 adults5 ith a mean age of 73 ± 7 years ( Jefferson et al., 2018 ). Chen et al.,
n a smaller study using 3T pCASL MRI, reported higher mean cortical
BF GM values of 52.6 ± 9.3, 52 ± 10.7 and 42.7 ± 8.8 ml/100 g/min in
ounger (mean age 30 ± 6 years, n = 11), middle-aged (mean age 52 ± 6
ears, n = 38) and older adults (mean age 71 ± 10 years, n = 37) respec-
ively ( Chen et al., 2011 ). The largest population-based MRI study to
ate using 2D phase-contrast MRI at 1.5T reported mean total cerebral
erfusion of 56.3 ± 9.7 ml/100 g/min in 4759 subjects with a mean age
f 64 ± 11 years ( Wolters et al., 2017 ). pCASL-MRI has an advantage
ver phase-contrast (PC) MRI, in that it directly measures CBF at a voxel
evel as opposed to measuring blood flow velocities through the internal
arotid and vertebral arteries, which can be used to calculate volumet-
ic blood flow to the brain ( Juttukonda and Donahue, 2019 ). Although
BF values measured with pCASL and PC MRI are similar, PC estimates
end to be higher and more variable ( Dolui et al., 2016 ). In a study of
41 healthy middle-aged subjects comparing pCASL and PC MRI at 3T,
olui et al. reported CBF values of 47.7 ± 9.8 ml/100 g/min with pCASL
ersus 55.8 ± 12.1 ml/100 g/min with PC MRI ( Dolui et al., 2016 ). 
Previous research has suggested that age-related decrease in cerebral
erfusion is potentially a consequence of cerebral atrophy, and/or de-
C.N. Leidhin, J. McMorrow, D. Carey et al. NeuroImage 229 (2021) 117741 
Table 2 
Age and sex (and education for MMSE) adjusted associations of demographic 
characteristics, cardiovascular risk factors and measures, medications and cogni- 
tive performance with grey matter cerebral blood flow (CBF GM [ml/100 g/min]). 
𝛽 (95% CI) P Value 
CBF GM [ml/100 g/min] ( N = 468) 
Education [Ref: Primary/None] 
Secondary 0.17 ( − 1.89 to 2.24) 0.870 
Third/Higher − 0.49 ( − 2.524 to 1.53) 0.631 
BMI [per 1 kg/m 2 ] − 0.35 ( − 0.51 to − 0.18) ≤ 0.001 
Self-reported diabetic [Ref: No] 
Yes − 1.06 ( − 3.56 to 1.45) 0.408 
Number of Cardiovascular Conditions a [Ref: 0] 
1 − 0.09 ( − 1.70 to 1.53) 0.916 
2 + − 0.43 ( − 2.43 to 1.157) 0.673 
High Blood Pressure [Ref: No] 
Yes − 0.95 ( − 2.51 to 0.6) 0.232 
High Cholesterol [Ref: No] 
Yes 0.78 ( − 0.77 to 2.33) 0.323 
PWV [per 1 m/s] − 0.11 ( − 0.51 to 0.29) 0.592 
Systolic BP [per 1 mmHg] − 0.06 ( − 0.10 to − 0.03) ≤ 0.001 
Diastolic BP [per 1 mmHg] − 0.14 ( − 0.20 to − 0.07) ≤ 0.001 
MAP [per 1 mmHg] − 0.11 ( − 0.17 to − 0.06) ≤ 0.001 
Antihypertensive Medication Use b [Ref: No] 
Yes − 0.86 ( − 2.35 to 0.63) 0.258 
CAGE Alcohol Scale [Ref: CAGE < 2] 
CAGE ≥ 2 − 1.31 ( − 3.03 to 0.40) 0.133 
No response − 1.43 ( − 3.87 to 1.02) 0.251 
Smoker [Ref: Never] 
Past − 0.95 ( − 2.43 to 0.53) 0.207 
Current − 0.27 ( − 3.46 to 2.92) 0.869 
CESD [Ref: CESD < 9] 
Depressed (CESD ≥ 9) 0.99 ( − 1.31 to 3.29) 0.397 
IRR (95% CI) P Value 
MMSE [per 1 error] c 1.00 (0.98 to 1.01) 0.411 
a Cardiovascular conditions: high cholesterol; angina; heart attack ever; heart 
failure, murmur, abnormal rhythm; stroke ever, TIA ever. 
b Coded using the Anatomical Therapeutic Chemical Classification (ATC): an- 
tihypertensive medications (ATC C02), diuretics (ATC C03), 𝛽-blockers (ATC 
C07), calcium channel blockers (ATC C08), and renin-angiotensin system agents 
(ATC C09). 
c Also adjusted for educational attainment. Abbreviations: CI, confidence in- 
tervals; BMI, body mass index; PWV, pulse wave velocity; BP, blood pressure; 
MAP, mean arterial pressure; CESD, Center for Epidemiologic Studies Depres- 
sion scale; MMSE, Mini-Mental State Examination; IRR, incidence rate ratio; 


























































































c  reased neuronal/metabolic activity and demand ( Parkes et al., 2004 ;
hang et al., 2017 ). However, this is not universally accepted as other
tudies have found regional reductions in CBF (using pCASL and surface-
ased analyses to map cerebral perfusion and cortical thickness) to be
ndependent of age-related atrophy ( Chen et al., 2011 ). The Rotterdam
tudy demonstrated the bidirectional nature of this relationship, report-
ng that smaller baseline brain volume results in steeper decrease in CBF
ver time. However, they also found that lower CBF at baseline is asso-
iated with accelerated brain atrophy, only in subjects aged 65 years or
lder ( Zonneveld et al., 2015 ). This finding suggests that the relation-
hip between CBF and atrophy is more complex in the older population.
Although this study assessed only CBF GM as a marker of global cere-
ral perfusion in older adults, prior studies have demonstrated regional
ge-related differences in CBF. Indeed, regions of both increased and de-
reased perfusion have been observed in cognitively normal older sub-
ects. For example, blood flow to the parietal cortex and precuneus may
e reduced, while other regions, including the temporal lobe, posterior
nd anterior cingulate cortex may demonstrate elevated CBF ( Lee et al.,
009 ; Preibisch et al., 2011 ; Zhang et al., 2018 ). Prior ASL studies have
emonstrated hypoperfusion of the posterior cingulate gyrus and pre-
uneus in patients with mild cognitive impairment/Alzheimer’s disease
 Thomas et al., 2019 ). Thus regional hypoperfusion in older subjects
ay indicate vulnerability to cognitive impairment/Alzheimer’s disease,
hereas hyperperfusion may represent a compensatory response. 6 The results presented in this study corroborate higher cerebral
erfusion in females compared to males, as reported previously
 Jennings et al., 2013 ; Liu et al., 2012 ; Parkes et al., 2004 ; Selim et al.,
008 ; Soni et al., 2016 ; Wolters et al., 2017 ), with a 3.1 ml/100 g/min
iscrepancy. While this cross-sectional study does not allow for causal
nference, previous research has suggested that this finding may reflect
ower haematocrit and blood viscosity and higher cerebral metabolic
ates for glucose and oxygen in women ( Tarumi and Zhang, 2018 ). 
Prior research indicates that obesity and hypertension can alter both
he structure and function of cerebral arteries, thereby decreasing the
ompliance of the cerebrovasculature ( Dorrance et al., 2014 ; Pires et al.,
013 ; Rogers et al., 1985 ). In addition, aortic stiffening caused by age-
ng and hypertension results in transmission of damaging high-pressure
ulsatility to the cerebral microvasculature ( de Roos et al., 2017 ). These
rocesses can increase the risk of cerebral hypoperfusion. It is unsurpris-
ng, therefore, that our study, as with prior research, demonstrates a
ignificant negative association between cardiovascular risk factors like
MI and CBF ( Beason-Held et al., 2007 ; Dai et al., 2008 ; Jennings et al.,
013 ; Muller et al., 2012 ; Selim et al., 2008 ; Vernooij et al., 2008 ;
illiamson et al., 2018 ). We found no significant association between
rey matter perfusion and self-reported type 2 diabetes, number of car-
iovascular conditions, hypercholesterolaemia, antihypertensive medi-
ation(s), CAGE score > 2 or smoking, likely due to the small numbers of
articipants with these conditions in our study sample. 
Accurate measurement of cerebral perfusion has proved challeng-
ng to date. Doppler ultrasound, like pCASL-MRI, is non-invasive, in-
olves no exposure to exogenous contrast nor ionising radiation and is
epeatable. However, it is highly operator dependent and estimation of
ow within the vertebral arteries is particularly challenging. Addition-
lly, measurements are limited to determination of arterial flow, which
s a poor surrogate for tissue perfusion. [ 15 O]-water positron emission
omography (PET), like pCASL MRI, quantitatively measures total and
egion-specific CBF but is invasive, costly, complex, not widely avail-
ble, requires injection of radioactive pharmaceuticals and exposure to
onising radiation and is therefore unsuitable for repeated studies. One
f the main strengths of the present study is the use of pCASL-MRI to
easure CBF. pCASL-MRI is a quantitative, non-invasive imaging tech-
ique, which does not employ ionising radiation nor exogenous con-
rast and which therefore potentially offers an acceptable method for
opulation-based CBF assessment ( Wintermark et al., 2005 ). Another
trength of the present work is that robust estimates of the normal de-
line in CBF with age were possible due to the large sample size with a
ontinuum of ages, and the robust statistical method (GAMLSS model)
mployed. 
Although all pCASL-MRI examinations were performed using a state-
f-the-art technique, guided by published recommendations, this tech-
ique is not without its limitations ( Alsop et al., 2015 ). One such limita-
ion is that the same labelling duration and delay were used in the acqui-
ition of all participants’ data, however, physiological inter-participant
ariations in cerebrovascular structure could impact these estimates and
ffect flow measurements, potentially leading to both under- and over-
stimation of CBF. The PLD used in this study may have been too short
o account for prolonged arterial transit times in older subjects, espe-
ially those with cerebrovascular disease. However, a PLD of 1800 ms
as felt to be the optimal choice in our subject cohort amongst whom
he mean age was less than 70 years. The ISMRM white paper recom-
ends a slice thickness of 4-8 mm with no slice gap. In our study, we
sed a slice thickness of 8 mm and a 1 mm slice gap. Due to partial
olume effects associated with thick slices, this may have resulted in
nderestimation of CBF ( Alsaedi et al., 2018 ). The thick slices used in
his study may also limit translatability of our results to other studies.
nother potential issue with pCASL is imperfect labelling due to flow
ffects in the arteries, resulting in underestimation of CBF. 
Although this study validates the notion that age and sex modify
erebral perfusion, the underlying mechanisms driving these changes
annot be determined in this cross-sectional study. Future waves of
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Table 3 
Normative values of pCASL-MRI cerebral perfusion stratified by age in male and female participants ( n = 468). 
Age [years] 
Percentile 54 59 64 69 74 79 84 
Male CBF GM 
P95 51.6 50.3 49.1 47.8 46.5 45.2 43.9 
P90 47.8 46.6 45.4 44.2 43.0 41.8 40.6 
P75 42.1 41.1 40.0 39.0 37.9 36.9 35.8 
P50 37.0 36.0 35.1 34.2 33.3 32.36 31.4 
P25 32.1 31.3 30.5 29.7 28.9 28.11 27.3 
P10 27.5 26.9 26.2 25.5 24.8 24.1 23.4 
P05 24.8 24.2 23.5 22.9 22.3 21.7 21.1 
Mean ± SD 37.6 ± 10.1 36.6 ± 9.9 35.7 ± 9.6 34.8 ± 9.4 33.8 ± 9.1 32.9 ± 8.9 31.9 ± 8.6 
Female CBF GM 
P95 56.3 55.1 53.8 52.5 51.2 49.9 48.6 
P90 52.1 50.9 49.8 48.6 47.4 46.2 45.0 
P75 46.0 44.9 43.9 42.8 41.8 40.7 39.7 
P50 40.3 39.4 38.5 37.6 36.7 35.7 34.8 
P25 35.1 34.3 33.5 32.7 31.9 31.1 30.3 
P10 30.1 29.4 28.7 28.0 27.3 26.6 26.0 
P05 27.0 26.4 25.8 25.2 24.6 24.0 23.3 
Mea 
n ± SD 41.0 ± 11.1 40.1 ± 10.8 39.1 ± 10.6 38.2 ± 10.3 37.3 ± 10.1 36.3 ± 9.8 35.4 ± 9.6 
Age corresponds to exact year of age; values for intermediate ages should be estimated by interpolation between supplied values. 




































































ILDA MRI data collection will facilitate longitudinal investigation into
he effects of age and sex on CBF. 
. Conclusion 
This study is by far the largest single-site study to present norma-
ive reference values for CBF GM measured at 3T using pCASL-MRI in an
ged community-dwelling cohort. These values will aid in the clinical
nterpretation of pCASL-MRI CBF GM measurements and in distinguish-
ng age-related decline in CBF GM from pathological reduction. Given the
ignificant effects of age and sex on CBF, these factors need to be taken
nto account when studying brain perfusion. 
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